{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:59:47Z","timestamp":1788562787420,"version":"build-2803163510"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":105,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas Grant 2029547"],"award-info":[{"award-number":["Ideas Grant 2029547"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas Grant 2029547"],"award-info":[{"award-number":["Ideas Grant 2029547"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Ideas Grant 2029547"],"award-info":[{"award-number":["Ideas Grant 2029547"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The ALS Foundation, Netherlands","award":["20200003"],"award-info":[{"award-number":["20200003"]}]},{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","award":["DIS-202403-01218"],"award-info":[{"award-number":["DIS-202403-01218"]}],"id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02159-w","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:16:35Z","timestamp":1764656195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human TDP-43 overexpression in zebrafish motor neurons triggers MND-like phenotypes through gain-of-function mechanism"],"prefix":"10.1186","volume":"14","author":[{"given":"Alison L.","family":"Hogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Maurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharlynn","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie M.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Don","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Morsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2159_CR1","doi-asserted-by":"crossref","unstructured":"de Boer EMJ, et al TDP-43 2021 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry 92(1):86\u201395. 10.1136\/jnnp-2020-322983","DOI":"10.1136\/jnnp-2020-322983"},{"key":"2159_CR2","doi-asserted-by":"publisher","unstructured":"Arai T et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093","DOI":"10.1016\/j.bbrc.2006.10.093"},{"key":"2159_CR3","doi-asserted-by":"publisher","unstructured":"Neumann M et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","DOI":"10.1126\/science.1134108"},{"key":"2159_CR4","doi-asserted-by":"publisher","unstructured":"Nelson PT et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142(6):1503\u20131527. https:\/\/doi.org\/10.1093\/brain\/awz099","DOI":"10.1093\/brain\/awz099"},{"issue":"1","key":"2159_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N (2021) TDP-43 pathology in alzheimer\u2019s disease. Mol Neurodegener 16(1):84. https:\/\/doi.org\/10.1186\/s13024-021-00503-x","journal-title":"Mol Neurodegener"},{"key":"2159_CR6","doi-asserted-by":"publisher","unstructured":"McCann EP et al (2017) The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet 92(3):259\u2013266. https:\/\/doi.org\/10.1111\/cge.12973","DOI":"10.1111\/cge.12973"},{"key":"2159_CR7","doi-asserted-by":"publisher","unstructured":"Mackenzie IRA, Rademakers R (2008) The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol 21:693\u2013700. https:\/\/doi.org\/10.1097\/WCO.0b013e3283168d1d","DOI":"10.1097\/WCO.0b013e3283168d1d"},{"key":"2159_CR8","doi-asserted-by":"publisher","unstructured":"Caroppo P et al (2016) Defining the spectrum of frontotemporal dementias associated with TARDBP mutations. Neurol Genet 2(3):e80. https:\/\/doi.org\/10.1212\/NXG.0000000000000080","DOI":"10.1212\/NXG.0000000000000080"},{"key":"2159_CR9","doi-asserted-by":"publisher","unstructured":"Lombardi M et al (2023) Variability in clinical phenotype in TARDBP mutations: amyotrophic lateral sclerosis case description and literature review. Genes 14(11). https:\/\/doi.org\/10.3390\/genes14112039","DOI":"10.3390\/genes14112039"},{"key":"2159_CR10","doi-asserted-by":"publisher","unstructured":"Mackenzie IRA et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61(5):427\u2013434. https:\/\/doi.org\/10.1002\/ana.21147","DOI":"10.1002\/ana.21147"},{"key":"2159_CR11","doi-asserted-by":"publisher","unstructured":"Dawson TM, Golde TE, Lagier-Tourenne C (2018) Animal models of neurodegenerative diseases. Nat Neurosci 21(10):1370\u20131379. https:\/\/doi.org\/10.1038\/s41593-018-0236-8","DOI":"10.1038\/s41593-018-0236-8"},{"issue":"10","key":"2159_CR12","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","volume":"52","author":"M Jo","year":"2020","unstructured":"Jo M, Lee S, Jeon Y-M, Kim S, Kwon Y, Kim H-J (2020) The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med 52(10):1652\u20131662. https:\/\/doi.org\/10.1038\/s12276-020-00513-7","journal-title":"Exp Mol Med"},{"issue":"1","key":"2159_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15(1):45. https:\/\/doi.org\/10.1186\/s13024-020-00397-1","journal-title":"Mol Neurodegener"},{"key":"2159_CR14","doi-asserted-by":"publisher","unstructured":"Nilaver BI, Urbanski HF (2023) Mechanisms underlying TDP-43 pathology and neurodegeneration: an updated mini-review, Front Aging Neurosci vol. 15 [Online]. Available: https:\/\/www.frontiersin.org\/journals\/aging-neuroscience\/articles\/https:\/\/doi.org\/10.3389\/fnagi.2023.1142617","DOI":"10.3389\/fnagi.2023.1142617"},{"key":"2159_CR15","doi-asserted-by":"publisher","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK 2019 Molecular Mechanisms of TDP-43 Misfolding and pathology in amyotrophic lateral sclerosis, Front Mol Neurosci 12:25 [Online]. Available: https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fnmol.2019.00025","DOI":"10.3389\/fnmol.2019.00025"},{"issue":"2","key":"2159_CR16","doi-asserted-by":"publisher","first-page":"e0255710","DOI":"10.1371\/journal.pone.0255710","volume":"17","author":"C Yang","year":"2022","unstructured":"Yang C et al (2022) Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice. PLoS ONE 17(2):e0255710. https:\/\/doi.org\/10.1371\/journal.pone.0255710","journal-title":"PLoS ONE"},{"key":"2159_CR17","doi-asserted-by":"publisher","unstructured":"Asakawa K, Handa H, Kawakami K (2023) Dysregulated TDP-43 proteostasis perturbs excitability of spinal motor neurons during brainstem-mediated fictive locomotion in zebrafish. DGD 65(8):446\u2013452. https:\/\/doi.org\/10.1111\/dgd.12879","DOI":"10.1111\/dgd.12879"},{"key":"2159_CR18","doi-asserted-by":"publisher","unstructured":"Wils H et al (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 107(8):3858\u20133863. https:\/\/doi.org\/10.1073\/pnas.0912417107","DOI":"10.1073\/pnas.0912417107"},{"key":"2159_CR19","doi-asserted-by":"publisher","unstructured":"Shan X, Chiang P-M, Price DL, Wong PC (2010) Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice., Proc. Natl. Acad. Sci. U. S. A., vol. 107, no. 37, pp. 16325\u201316330, Sep. https:\/\/doi.org\/10.1073\/pnas.1003459107","DOI":"10.1073\/pnas.1003459107"},{"key":"2159_CR20","doi-asserted-by":"publisher","unstructured":"Schmid B et al (2013) Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci 110(13):4986\u20134991. https:\/\/doi.org\/10.1073\/pnas.1218311110","DOI":"10.1073\/pnas.1218311110"},{"key":"2159_CR21","doi-asserted-by":"publisher","unstructured":"Bose P, Armstrong GAB, Drapeau P (2019) Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43. J Neurophysiol 121(1):285\u2013297. https:\/\/doi.org\/10.1152\/jn.00265.2018","DOI":"10.1152\/jn.00265.2018"},{"key":"2159_CR22","doi-asserted-by":"publisher","unstructured":"Campanari M-L, Marian A, Ciura S, Kabashi E (2021) TDP-43 regulation of ache expression can mediate ALS-Like phenotype in zebrafish. Cells 10(2). https:\/\/doi.org\/10.3390\/cells10020221","DOI":"10.3390\/cells10020221"},{"issue":"1","key":"2159_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41467-020-14815-x","volume":"11","author":"K Asakawa","year":"2020","unstructured":"Asakawa K, Handa H, Kawakami K (2020) Optogenetic modulation of TDP-43 oligomerization accelerates ALS-related pathologies in the spinal motor neurons. Nat Commun 11(1):1004. https:\/\/doi.org\/10.1038\/s41467-020-14815-x","journal-title":"Nat Commun"},{"key":"2159_CR24","doi-asserted-by":"publisher","unstructured":"Lissouba A, Liao M, Kabashi E, Drapeau P (2018) Transcriptomic Analysis of Zebrafish TDP-43 Transgenic Lines. Front Mol Neurosci vol. 11 [Online]. Available: https:\/\/www.frontiersin.org\/journals\/molecular-neuroscience\/articles\/https:\/\/doi.org\/10.3389\/fnmol.2018.00463","DOI":"10.3389\/fnmol.2018.00463"},{"key":"2159_CR25","doi-asserted-by":"publisher","unstructured":"Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 106(44):18809\u201318814. https:\/\/doi.org\/10.1073\/pnas.0908767106","DOI":"10.1073\/pnas.0908767106"},{"key":"2159_CR26","doi-asserted-by":"publisher","unstructured":"Fratta P et al (2018) Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J 37(11). https:\/\/doi.org\/10.15252\/embj.201798684","DOI":"10.15252\/embj.201798684"},{"key":"2159_CR27","doi-asserted-by":"publisher","unstructured":"Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL (2010) Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis 40(2)404\u2013414. https:\/\/doi.org\/10.1016\/j.nbd.2010.06.017","DOI":"10.1016\/j.nbd.2010.06.017"},{"key":"2159_CR28","doi-asserted-by":"publisher","unstructured":"Zhou H et al (2010) Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet 6(3):e1000887. https:\/\/doi.org\/10.1371\/journal.pgen.1000887","DOI":"10.1371\/journal.pgen.1000887"},{"issue":"1","key":"2159_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1750-1326-6-73","volume":"6","author":"Y-F Xu","year":"2011","unstructured":"Xu Y-F et al (2011) Expression of mutant TDP-43 induces neuronal dysfunction in Transgenic mice. Mol Neurodegener 6(1):73. https:\/\/doi.org\/10.1186\/1750-1326-6-73","journal-title":"Mol Neurodegener"},{"key":"2159_CR30","doi-asserted-by":"publisher","unstructured":"Swarup V et al (2011) Pathological hallmarks of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134(9):2610\u20132626. https:\/\/doi.org\/10.1093\/brain\/awr159","DOI":"10.1093\/brain\/awr159"},{"key":"2159_CR31","doi-asserted-by":"publisher","unstructured":"Kabashi E et al (2009) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19(4):671\u2013683. https:\/\/doi.org\/10.1093\/hmg\/ddp534","DOI":"10.1093\/hmg\/ddp534"},{"issue":"1","key":"2159_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-024-00735-7","volume":"19","author":"Y Hu","year":"2024","unstructured":"Hu Y et al (2024) Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits. Mol Neurodegener 19(1):50. https:\/\/doi.org\/10.1186\/s13024-024-00735-7","journal-title":"Mol Neurodegener"},{"key":"2159_CR33","doi-asserted-by":"publisher","unstructured":"Walker AK et al (2015) Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol 130(5):643\u2013660. https:\/\/doi.org\/10.1007\/s00401-015-1460-x","DOI":"10.1007\/s00401-015-1460-x"},{"key":"2159_CR34","doi-asserted-by":"publisher","unstructured":"Igaz LM et al (2011) Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 121(2):726\u2013738. https:\/\/doi.org\/10.1172\/JCI44867","DOI":"10.1172\/JCI44867"},{"issue":"3","key":"2159_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 22(3):185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2","journal-title":"Nat Rev Drug Discov"},{"key":"2159_CR36","doi-asserted-by":"publisher","unstructured":"Melamed Z et al (2019) Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci 22(2):180\u2013190. https:\/\/doi.org\/10.1038\/s41593-018-0293-z","DOI":"10.1038\/s41593-018-0293-z"},{"issue":"7899","key":"2159_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR et al (2022) TDP-43 represses cryptic exon inclusion in the FTD\u2013ALS gene UNC13A. Nature 603(7899):124\u2013130. https:\/\/doi.org\/10.1038\/s41586-022-04424-7","journal-title":"Nature"},{"key":"2159_CR38","doi-asserted-by":"publisher","unstructured":"Scherer NM et al (2024) RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation  in vivo. Nucleic Acids Res 52(9):5301\u20135319. https:\/\/doi.org\/10.1093\/nar\/gkae112","DOI":"10.1093\/nar\/gkae112"},{"issue":"3","key":"2159_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-018-1875-2","volume":"136","author":"AJ Svahn","year":"2018","unstructured":"Svahn AJ et al (2018) Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons. Acta Neuropathol 136(3):445\u2013459. https:\/\/doi.org\/10.1007\/s00401-018-1875-2","journal-title":"Acta Neuropathol"},{"key":"2159_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fncel.2015.00321","volume":"9","author":"M Morsch","year":"2015","unstructured":"Morsch M et al (2015)  In vivo characterization of microglial engulfment of dying neurons in the zebrafish spinal cord. Front Cell Neurosci 9:321. https:\/\/doi.org\/10.3389\/fncel.2015.00321","journal-title":"Front Cell Neurosci"},{"key":"2159_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.redox.2018.08.011","volume":"19","author":"I Formella","year":"2018","unstructured":"Formella I et al (2018) Real-time visualization of oxidative stress-mediated neurodegeneration of individual spinal motor neurons  in vivo. Redox Biol 19:226\u2013234. https:\/\/doi.org\/10.1016\/j.redox.2018.08.011","journal-title":"Redox Biol"},{"key":"2159_CR42","doi-asserted-by":"publisher","unstructured":"B\u00e9rard M et al 2022 A light-inducible protein clustering system for  in vivo analysis of \u03b1-synuclein aggregation in Parkinson disease. PLOS Biol 20(3):e3001578 [Online]. Available: https:\/\/doi.org\/10.1371\/journal.pbio.3001578","DOI":"10.1371\/journal.pbio.3001578"},{"issue":"7","key":"2159_CR43","doi-asserted-by":"publisher","first-page":"112761","DOI":"10.1016\/j.isci.2025.112761","volume":"28","author":"C Maurel","year":"2025","unstructured":"Maurel C et al (2025) Critical impact of lysine 136 in TDP-43 phase separation, compartmentalization, and aggregation in living vertebrates. iScience 28(7):112761. https:\/\/doi.org\/10.1016\/j.isci.2025.112761","journal-title":"iScience"},{"key":"2159_CR44","unstructured":"Westerfield M (2007) The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 5th ed"},{"key":"2159_CR45","doi-asserted-by":"publisher","unstructured":"Don EK et al (2017) A Tol2 Gateway-Compatible toolbox for the study of the nervous system and neurodegenerative disease. Zebrafish 14(1):69\u201372. https:\/\/doi.org\/10.1089\/zeb.2016.1321","DOI":"10.1089\/zeb.2016.1321"},{"key":"2159_CR46","doi-asserted-by":"publisher","unstructured":"Rayner SL et al (2021) ALS\/FTD-causing mutation in Cyclin F causes the dysregulation of SFPQ. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddab073","DOI":"10.1093\/hmg\/ddab073"},{"key":"2159_CR47","doi-asserted-by":"publisher","unstructured":"Hogan AL et al (2017) Expression of ALS\/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype. Hum Mol Genet 26(14)2616\u20132626. https:\/\/doi.org\/10.1093\/hmg\/ddx136","DOI":"10.1093\/hmg\/ddx136"},{"key":"2159_CR48","doi-asserted-by":"publisher","unstructured":"Lemmens R et al (2007) Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum Mol Genet 16(19):2359\u20132365. https:\/\/doi.org\/10.1093\/hmg\/ddm193","DOI":"10.1093\/hmg\/ddm193"},{"key":"2159_CR49","doi-asserted-by":"publisher","unstructured":"Kwan KM et al (2007) The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn Off Publ Am Assoc Anat 236(11)3088\u20133099. https:\/\/doi.org\/10.1002\/dvdy.21343","DOI":"10.1002\/dvdy.21343"},{"key":"2159_CR50","doi-asserted-by":"publisher","unstructured":"Taverna E et al (2016) Non-canonical features of the golgi apparatus in bipolar epithelial neural stem cells. Sci Rep 6:21206. https:\/\/doi.org\/10.1038\/srep21206","DOI":"10.1038\/srep21206"},{"key":"2159_CR51","doi-asserted-by":"publisher","unstructured":"Fukuda Y et al (2020) Binding and transport of SFPQ-RNA granules by KIF5A\/KLC1 motors promotes axon survival. J Cell Biol 220(1). https:\/\/doi.org\/10.1083\/jcb.202005051","DOI":"10.1083\/jcb.202005051"},{"issue":"1","key":"2159_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13073-021-00900-3","volume":"13","author":"I Mannucci","year":"2021","unstructured":"Mannucci I et al (2021) Genotype\u2013phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders. Genome Med 13(1):90. https:\/\/doi.org\/10.1186\/s13073-021-00900-3","journal-title":"Genome Med"},{"key":"2159_CR53","doi-asserted-by":"publisher","unstructured":"Tse N et al (2014) The neuromuscular junction: measuring synapse size, fragmentation and changes in synaptic protein density using confocal fluorescence microscopy., J Vis Exp no. 94. https:\/\/doi.org\/10.3791\/52220","DOI":"10.3791\/52220"},{"key":"2159_CR54","doi-asserted-by":"publisher","unstructured":"Rock S, Rodenburg F, Schaaf MJM, Tudorache C (2022) Detailed analysis of zebrafish larval behaviour in the light dark challenge assay shows that diel hatching time determines individual variation, Front Physiol vol. 13 [Online]. Available: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fphys.2022.827282","DOI":"10.3389\/fphys.2022.827282"},{"issue":"1","key":"2159_CR55","doi-asserted-by":"publisher","first-page":"14454","DOI":"10.1038\/s41598-024-64933-5","volume":"14","author":"F Saputra","year":"2024","unstructured":"Saputra F, Kishida M, Hu S-Y (2024) Oxidative stress induced by hydrogen peroxide disrupts zebrafish visual development by altering apoptosis, antioxidant and Estrogen related genes. Sci Rep 14(1):14454. https:\/\/doi.org\/10.1038\/s41598-024-64933-5","journal-title":"Sci Rep"},{"key":"2159_CR56","doi-asserted-by":"publisher","unstructured":"McGown A, Shaw P, Ramesh T (2016) ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the Transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis. Mol Neurodegener 11. https:\/\/doi.org\/10.1186\/s13024-016-0122-3","DOI":"10.1186\/s13024-016-0122-3"},{"key":"2159_CR57","doi-asserted-by":"publisher","unstructured":"Smith LL, Beggs AH, Gupta VA (2013) Analysis of skeletal muscle defects in larval zebrafish by birefringence and touch-evoke escape response assays. J Vis Exp no. 82:e50925. https:\/\/doi.org\/10.3791\/50925","DOI":"10.3791\/50925"},{"key":"2159_CR58","doi-asserted-by":"publisher","unstructured":"Shaw MP et al (2018) Stable Transgenic C9orf72 zebrafish model key aspects of the ALS\/FTD phenotype and reveal novel pathological features. Acta Neuropathol Commun 6(1):125. https:\/\/doi.org\/10.1186\/s40478-018-0629-7","DOI":"10.1186\/s40478-018-0629-7"},{"key":"2159_CR59","doi-asserted-by":"publisher","unstructured":"Saint-Amant L, Drapeau P (1998) Time course of the development of motor behaviors in the zebrafish embryo. J Neurobiol 37(4):622\u2013632. https:\/\/doi.org\/10.1002\/(sici)1097-4695(199812)37:4%3C622::aid-neu10%3E3.0.co;2-s","DOI":"10.1002\/(sici)1097-4695(199812)37:4%3C622::aid-neu10%3E3.0.co;2-s"},{"key":"2159_CR60","doi-asserted-by":"publisher","unstructured":"Robinson KJ et al (2019) Motor Neuron Abnormalities Correlate with Impaired Movement in Zebrafish that Express Mutant Superoxide Dismutase 1. Zebrafish 16(1):8\u201314. https:\/\/doi.org\/10.1089\/zeb.2018.1588","DOI":"10.1089\/zeb.2018.1588"},{"key":"2159_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semcdb.2019.07.010","volume":"99","author":"W Guo","year":"2020","unstructured":"Guo W, Stoklund Dittlau K, Van Den Bosch L (2020) Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Semin Cell Dev Biol 99:133\u2013150. https:\/\/doi.org\/10.1016\/j.semcdb.2019.07.010","journal-title":"Semin Cell Dev Biol"},{"key":"2159_CR62","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-0716-1990-2_17","volume":"2431","author":"M Atkins","year":"2022","unstructured":"Atkins M, Hazan J, Fassier C (2022)  In vivo live imaging of axonal transport in developing zebrafish axons. Methods Mol Biol 2431:325\u2013350. https:\/\/doi.org\/10.1007\/978-1-0716-1990-2_17","journal-title":"Methods Mol Biol"},{"key":"2159_CR63","doi-asserted-by":"publisher","unstructured":"Verma S et al (2022) Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol Neurobiol 59(3):1502\u20131527. https:\/\/doi.org\/10.1007\/s12035-021-02658-6","DOI":"10.1007\/s12035-021-02658-6"},{"key":"2159_CR64","doi-asserted-by":"publisher","unstructured":"Brisendine MH et al (2024) Neuromuscular dysfunction precedes cognitive impairment in a mouse model of alzheimer\u2019s disease. Function 5(1):zqad066. https:\/\/doi.org\/10.1093\/function\/zqad066","DOI":"10.1093\/function\/zqad066"},{"issue":"1","key":"2159_CR65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuro.2008.09.011","volume":"30","author":"RC MacPhail","year":"2009","unstructured":"MacPhail RC, Brooks J, Hunter DL, Padnos B, Irons TD, Padilla S (2009) Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 30(1):52\u201358. https:\/\/doi.org\/10.1016\/j.neuro.2008.09.011","journal-title":"Neurotoxicology"},{"key":"2159_CR66","doi-asserted-by":"publisher","unstructured":"Colombrita C et al (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 111(4):1051\u20131061. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06383.x","DOI":"10.1111\/j.1471-4159.2009.06383.x"},{"key":"2159_CR67","doi-asserted-by":"publisher","unstructured":"Goh CW et al (2018) Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration. J Biol Chem 293(1):163\u2013176. https:\/\/doi.org\/10.1074\/jbc.M117.814111","DOI":"10.1074\/jbc.M117.814111"},{"issue":"2","key":"2159_CR68","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41594-020-00537-7","volume":"28","author":"X Zuo","year":"2021","unstructured":"Zuo X et al (2021) TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat Struct Mol Biol 28(2):132\u2013142. https:\/\/doi.org\/10.1038\/s41594-020-00537-7","journal-title":"Nat Struct Mol Biol"},{"key":"2159_CR69","doi-asserted-by":"publisher","unstructured":"Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47(6 Suppl 4):S233-41. https:\/\/doi.org\/10.1212\/wnl.47.6_suppl_4.233s","DOI":"10.1212\/wnl.47.6_suppl_4.233s"},{"key":"2159_CR70","doi-asserted-by":"publisher","unstructured":"Cha SJ, Kim K (2022) Effects of the Edaravone, a drug approved for the treatment of amyotrophic lateral Sclerosis, on mitochondrial function and neuroprotection. Antioxid (Basel Switzerland) 11(2). https:\/\/doi.org\/10.3390\/antiox11020195","DOI":"10.3390\/antiox11020195"},{"key":"2159_CR71","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.freeradbiomed.2024.03.016","volume":"217","author":"NAS Oliveira","year":"2024","unstructured":"Oliveira NAS, Pinho BR, Pinto J, Guedes de Pinho P, Oliveira JMA (2024) Edaravone counteracts redox and metabolic disruptions in an emerging zebrafish model of sporadic ALS. Free Radic Biol Med 217:126\u2013140. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.03.016","journal-title":"Free Radic Biol Med"},{"key":"2159_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dmm.005538","volume":"3","author":"T Ramesh","year":"2010","unstructured":"Ramesh T et al (2010) A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech 3:9\u201310. https:\/\/doi.org\/10.1242\/dmm.005538","journal-title":"Dis Model Mech"},{"issue":"5","key":"2159_CR73","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s10895-023-03382-1","volume":"34","author":"Y Huang","year":"2024","unstructured":"Huang Y et al (2024) Practical characterization strategies for Comparison, Qualification, and selection of cell viability detection methods for cellular therapeutic product development and manufacturing. J Fluoresc 34(5):2263\u20132278. https:\/\/doi.org\/10.1007\/s10895-023-03382-1","journal-title":"J Fluoresc"},{"key":"2159_CR74","doi-asserted-by":"publisher","unstructured":"Kabashi E et al 2011 FUS and TARDBP but Not SOD1 Interact in genetic models of amyotrophic lateral sclerosis. PLOS Genet 7(8):e1002214 [Online]. Available: https:\/\/doi.org\/10.1371\/journal.pgen.1002214","DOI":"10.1371\/journal.pgen.1002214"},{"key":"2159_CR75","doi-asserted-by":"publisher","first-page":"104935","DOI":"10.1016\/j.nbd.2020.104935","volume":"142","author":"A-R Bourefis","year":"2020","unstructured":"Bourefis A-R, Campanari M-L, Buee-Scherrer V, Kabashi E (2020) Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS. Neurobiol Dis 142:104935. https:\/\/doi.org\/10.1016\/j.nbd.2020.104935","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2159_CR76","doi-asserted-by":"publisher","first-page":"e42117","DOI":"10.1371\/journal.pone.0042117","volume":"7","author":"A Vaccaro","year":"2012","unstructured":"Vaccaro A et al (2012) Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio. PLoS ONE 7(7):e42117. https:\/\/doi.org\/10.1371\/journal.pone.0042117","journal-title":"PLoS ONE"},{"issue":"1","key":"2159_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-7-44","volume":"7","author":"SA Sakowski","year":"2012","unstructured":"Sakowski SA et al (2012) Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol Neurodegener 7(1):44. https:\/\/doi.org\/10.1186\/1750-1326-7-44","journal-title":"Mol Neurodegener"},{"key":"2159_CR78","doi-asserted-by":"publisher","unstructured":"Swaminathan A et al (2018) Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model. Hum Mol Genet 27(10):1754\u20131762. https:\/\/doi.org\/10.1093\/hmg\/ddy083","DOI":"10.1093\/hmg\/ddy083"},{"issue":"3","key":"2159_CR79","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-017-1796-5","volume":"135","author":"B Swinnen","year":"2018","unstructured":"Swinnen B et al (2018) A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol 135(3):427\u2013443. https:\/\/doi.org\/10.1007\/s00401-017-1796-5","journal-title":"Acta Neuropathol"},{"key":"2159_CR80","doi-asserted-by":"publisher","unstructured":"Armstrong GAB, Drapeau P (2013) Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet 22(21):4282\u20134292. https:\/\/doi.org\/10.1093\/hmg\/ddt278","DOI":"10.1093\/hmg\/ddt278"},{"key":"2159_CR81","doi-asserted-by":"publisher","unstructured":"Da Costa MMJ, Allen CE, Higginbottom A, Ramesh T, Shaw PJ, McDermott CJ (2014) A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for  in vivo therapeutic screening. Dis Model Mech 7(1):73\u201381. https:\/\/doi.org\/10.1242\/dmm.012013","DOI":"10.1242\/dmm.012013"},{"key":"2159_CR82","doi-asserted-by":"publisher","unstructured":"Harji ZA et al (2025) TARDBP (TDP-43) Knock-in zebrafish display a Late-Onset motor phenotype and loss of large spinal cord motor neurons. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.78012","DOI":"10.1002\/ana.78012"},{"key":"2159_CR83","doi-asserted-by":"publisher","unstructured":"Keating SS, San Gil R, Swanson MEV, Scotter EL, Walker AK (2022) TDP-43 pathology: from noxious assembly to therapeutic removal. Prog Neurobiol 211:102229. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102229","DOI":"10.1016\/j.pneurobio.2022.102229"},{"key":"2159_CR84","doi-asserted-by":"publisher","unstructured":"Avenda\u00f1o-V\u00e1zquez SE, Dhir A, Bembich S, Buratti E, Proudfoot N, Baralle FE (2012) Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 26(15):1679\u20131684. https:\/\/doi.org\/10.1101\/gad.194829.112","DOI":"10.1101\/gad.194829.112"},{"key":"2159_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fcell.2019.00017","volume":"7","author":"V Bercier","year":"2019","unstructured":"Bercier V, Rosello M, Bene FD, Revenu C (2019) Zebrafish as a model for the study of live  in vivo processive transport in neurons. Front Cell Dev Biol 7:17. https:\/\/doi.org\/10.3389\/fcell.2019.00017","journal-title":"Front Cell Dev Biol"},{"key":"2159_CR86","doi-asserted-by":"publisher","unstructured":"Alami NH et al (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81(3):536\u2013543. https:\/\/doi.org\/10.1016\/j.neuron.2013.12.018","DOI":"10.1016\/j.neuron.2013.12.018"},{"key":"2159_CR87","doi-asserted-by":"publisher","unstructured":"Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM (1997) Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 139(5):1307\u20131315. https:\/\/doi.org\/10.1083\/jcb.139.5.1307","DOI":"10.1083\/jcb.139.5.1307"},{"key":"2159_CR88","doi-asserted-by":"publisher","unstructured":"Williamson TL, Cleveland DW (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2(1):50\u201356. https:\/\/doi.org\/10.1038\/4553","DOI":"10.1038\/4553"},{"key":"2159_CR89","doi-asserted-by":"publisher","unstructured":"Fallini C, Bassell GJ, Rossoll W (2012) The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet 21(16):3703\u20133718. https:\/\/doi.org\/10.1093\/hmg\/dds205","DOI":"10.1093\/hmg\/dds205"},{"key":"2159_CR90","doi-asserted-by":"publisher","unstructured":"Polymenidou M et al (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14(4):459\u2013468. https:\/\/doi.org\/10.1038\/nn.2779","DOI":"10.1038\/nn.2779"},{"key":"2159_CR91","doi-asserted-by":"publisher","unstructured":"Tripathi VB, Baskaran P, Shaw CE, Guthrie S (2014) Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and  in vivo. Neurobiol Dis 65(100):25\u201334. https:\/\/doi.org\/10.1016\/j.nbd.2014.01.004","DOI":"10.1016\/j.nbd.2014.01.004"},{"issue":"1","key":"2159_CR92","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.1038\/s41467-024-52706-7","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H et al (2024) TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport. Nat Commun 15(1):9026. https:\/\/doi.org\/10.1038\/s41467-024-52706-7","journal-title":"Nat Commun"},{"key":"2159_CR93","doi-asserted-by":"publisher","unstructured":"Al-Chalabi A et al (2014) Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 13(11):1108\u20131113. https:\/\/doi.org\/10.1016\/S1474-4422(14)70219-4","DOI":"10.1016\/S1474-4422(14)70219-4"},{"key":"2159_CR94","doi-asserted-by":"publisher","unstructured":"Gerovska D, Ara\u00fazo-Bravo MJ (2022) The common incidence-age multistep model of neurodegenerative diseases revisited: wider general age range of incidence corresponds to fewer disease steps. Cell Biosci 12(1). https:\/\/doi.org\/10.1186\/s13578-021-00737-8","DOI":"10.1186\/s13578-021-00737-8"},{"key":"2159_CR95","doi-asserted-by":"publisher","unstructured":"McGown A et al (2013) Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish model. Ann Neurol 73(2):246\u2013258. https:\/\/doi.org\/10.1002\/ana.23780","DOI":"10.1002\/ana.23780"},{"key":"2159_CR96","doi-asserted-by":"publisher","unstructured":"Wright AL et al (2021) Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 54(6):6237\u20136255. https:\/\/doi.org\/10.1111\/ejn.15422","DOI":"10.1111\/ejn.15422"},{"key":"2159_CR97","doi-asserted-by":"publisher","unstructured":"Arnold ES et al (2013) ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci 110(8):E736\u2013E745. https:\/\/doi.org\/10.1073\/pnas.1222809110","DOI":"10.1073\/pnas.1222809110"},{"key":"2159_CR98","doi-asserted-by":"publisher","unstructured":"Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30(2):639\u2013649. https:\/\/doi.org\/10.1523\/JNEUROSCI.4988-09.2010","DOI":"10.1523\/JNEUROSCI.4988-09.2010"},{"key":"2159_CR99","doi-asserted-by":"publisher","unstructured":"Ebstein SY, Yagudayeva I, Shneider NA (2019) Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a\u2009<\u2009em\u2009>\u2009TARDBP\u2009Knockin mouse model of ALS. Cell Rep 26(2):364\u2013373. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.045","DOI":"10.1016\/j.celrep.2018.12.045"},{"issue":"1","key":"2159_CR100","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-023-00608-5","volume":"18","author":"PR Mehta","year":"2023","unstructured":"Mehta PR, Brown A-L, Ward ME, Fratta P (2023) The era of cryptic exons: implications for ALS-FTD. Mol Neurodegener 18(1):16. https:\/\/doi.org\/10.1186\/s13024-023-00608-5","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2159_CR101","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.celrep.2016.08.071","volume":"17","author":"JP Ling","year":"2016","unstructured":"Ling JP et al (2016) PTBP1 and PTBP2 repress nonconserved cryptic exons. Cell Rep 17(1):104\u2013113. https:\/\/doi.org\/10.1016\/j.celrep.2016.08.071","journal-title":"Cell Rep"},{"key":"2159_CR102","doi-asserted-by":"publisher","unstructured":"Jeong YH et al (2017) Tdp-43 cryptic exons are highly variable between cell types. Mol Neurodegener 12(1):13. https:\/\/doi.org\/10.1186\/s13024-016-0144-x","DOI":"10.1186\/s13024-016-0144-x"},{"issue":"10","key":"2159_CR103","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15(10):565\u2013581. https:\/\/doi.org\/10.1038\/s41582-019-0244-7","journal-title":"Nat Rev Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02159-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:02:51Z","timestamp":1773799371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02159-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2159"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02159-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were performed in compliance with the Macquarie University Animal Ethics Committee (ARA 2015\/033, 2017\/019) and the Macquarie University Biosafety Committee (NLRD 18570\u201352019597412350).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}